clinic based intervention
Othercounseling C&T clients on FP; offering condoms, pills and injectables; and referring clients for other FP methods
NCT Number: NCT01903889
The study employs a quasi-experimental design in 8 public health centers in southwest Uganda offering care and treatment (C&T) services. In 4 health centers, a basic intervention is introduced, whereby HIV/AIDS providers are trained on contraception for HIV-positive women. They are charged with counseling C&T clients on FP; offering condoms, pills and injectables; and referring clients for other FP methods. In the other 4 health centers, the basic intervention is introduced along with an intervention for constructive male engagement in HIV and FP services. This includes training of C&T providers on gender-based influences on health behaviors; provision of couples' HIV testing and FP counseling services; and community-based education for men to promote gender equitable norms and male participation in health services.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Bukinda Health Center, Kabale, Uganda
This study will be conducted in Kabale District, Uganda, a rural district where prevention of mother to child transmission (PMTCT) and care and treatment (C&T) services are offered in eight public sector health facilities. The primary aim of this study is to test an intervention for increasing use of the full spectrum of PMTCT services, including family planning (FP), through enhanced constructive male involvement in reproductive health decision making. This aim will be accomplished by conducting a cluster randomized trial, whereby a "constructive male engagement" intervention package will be introduced in four randomly selected health centers and surrounding communities; the other four sites will serve as comparisons. Pre- and post-intervention cross sectional surveys will be conducted with male and female C&T clients to assess intervention effectiveness, measured in terms of dual method use. In addition to the male engagement intervention, reinforcements will be introduced in all eight participating facilities to enhance providers' capacity to serve the FP needs of C&T clients. We hypothesize that the percentage of clients reporting dual method use will increase slightly in all facilities as a result of this "HIV-FP integration intervention." To measure the independent effect of the reinforcements, the study will compare contraceptive knowledge, attitudes, and behaviors of clients measured pre- and post-intervention in the comparison sites only, in the absence of the male engagement intervention. We further hypothesize that improvements will be incrementally greater in the four facilities exposed to the additional constructive male engagement intervention.
The study will include additional data collection and analyses to support secondary objectives.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
female participants
male participants
Exclusion criteria
counseling C&T clients on FP; offering condoms, pills and injectables; and referring clients for other FP methods
basic intervention is introduced along with an intervention for constructive male engagement in HIV and FP services
Time frame: 12 months
Dual method use among couples with at least one partner using C&T services
Time frame: 6 months
Number of new ANC clients
Time frame: 12 months
Dual method use among couples with at least one partner using C&T services 2) Knowledge and attitudes related to FP
Time frame: 1 month
Time frame: 10 months
Time frame: 12 months
Cost of implementing HIV-FP integration intervention and male engagement intervention.
FHI 360
Other
Promoting Constructive Male Engagement to Increase Use of Prevention of Mother to Child Transmission (PMTCT) Services
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03733093
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Kakata, Liberia
View Trial DetailsNCT05708014
Acquired Immunodeficiency Syndrome, Behavior
Miami, Florida, United States
View Trial DetailsNCT05504954
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Cape Town, Western Cape, South Africa
View Trial DetailsNCT05873855
Acquired Immunodeficiency Syndrome, Behavior
Miami, Florida, United States
View Trial Details